Clinical and Scientific Advisory Board

Maurizio Fava, M.D.
Professor, Harvard Medical School

Dr. Maurizio Fava is Professor of Psychiatry at Harvard Medical School, Executive Vice Chair of the Department of Psychiatry and Director of the Depression Research Program at Massachusetts General Hospital. His major research interests are the development of effective short-term and long-term strategies in the treatment of depression and several depressive subtypes. Dr. Fava has conducted a number of clinical investigations in the area of treatment-resistant depression and short-term and long-term tolerability issues during antidepressant treatment. He has authored and co-authored more than 400 original articles, edited five books and is widely published in international medical journals. Dr. Fava is a well-known national and international speaker in the field of psychiatry. Dr. Fava obtained his medical degree from the University of Padova School of Medicine, where he also completed his residency training in endocrinology. He then moved to the U.S. and completed residency training in psychiatry at Massachusetts General Hospital in Boston.

Fred Gage, Ph.D.
Professor, Salk Institute

Gage Salk Institute: http://www.salk.edu/faculty/gage.html
Dr. Gage is a professor in the Laboratory of Genetics and the Vi and John Adler Chair for Research on Age-Related Neurodegenerative Diseases at the Salk Institute for Biological Studies. Dr. Gage is a co-founder of BrainCells. His work concentrates on the adult central nervous system and unexpected plasticity and adaptability to environmental stimulation that remains throughout the life of all mammals. In addition, his studies focus on the cellular, molecular, as well as environmental influences that regulate neurogenesis in the adult mammalian brain. He has won numerous prizes and awards for his work including the IPSEN Prize for Neuroplasticity, the Charles A. Dana Award, Metropolitan Life Research Award and the Keio Medical Science Prize. He serves on many health related boards, and was President of the Society for Neuroscience and is President-Elect of the International Society for Stem Cell Research. He is a Fellow of the American Association for the Advancement of Science, a Member of the National Academy of Sciences and the Institute of Medicine, and a Member of the American Academy of Arts and Sciences.

Andrew Nierenberg, M.D.
Professor, Harvard Medical School

Dr. Andrew Nierenberg is Professor of Psychiatry at Harvard Medical School and Associate Director of the Depression Clinical and Research Program,and Co-Director of the Bipolar Program at Massachusetts General Hospital. His primary interests are effectiveness trials in bipolar disorder, treatment resistant depression, management of antidepressant side effects, the longitudinal course of affective disorders, and pharmacoepidemiology. Having published over 270 original articles, chapters, reviews, and abstracts, Dr. Nierenberg has been listed among the Best Doctors in North America for the treatment of mood and anxiety disorders since 1994. Dr. Nierenberg is the Director of the NIMH Bipolar Trials Network and PI of the LiTMUS study, an effectiveness study of the use of tolerable doses of lithium for bipolar disorder. He is editor-in-chief of CNS Spectrums. Dr. Nierenberg is a graduate of the Albert Einstein College of Medicine of Yeshiva University, Bronx, New York. He did his residency in psychiatry at New York University/Bellevue Hospital in New York City and was a Robert Wood Clinical Scholar at Yale University.

Mark Rapaport, M.D.
Chair, Emory University School of Medicine

Dr. Mark Hyman Rapaport is the Chair of the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine. Prior to his position at Emory, Dr. Rapaport was Chairman and Professor in the Department of Psychiatry and Behavioral Neurosciences at Cedars-Sinai Medical Center where he held the Polier Endowed Chair in Schizophrenia and Related Disorders. He was also Vice Chair of the Department of Psychiatry and Professor of Psychiatry at the University of California, Los Angeles (UCLA). Dr. Rapaport’s research interests are focused on psychopharmacology, investigating the biologic genesis of anxiety disorders, bipolar disorder, depression, and immunity abnormalities in schizophrenia. Dr. Rapaport has written over 179 articles for such peer-reviewed publications as American Journal of Psychiatry, Biological Psychiatry, Journal of Clinical Psychiatry and Neuropsychopharmacology. He currently serves as Co-Editor and Chief of FOCUS: The Journal of Lifelong Learning in Psychiatry. Dr. Rapaport is a member of the American College of Psychiatrists, American Society of Clinical Psychopharmacology, Anxiety Disorders Association of America, the Psychiatric Research Society and the Collegium International Neuropsychopharmacology (CINP). He is a fellow of the American Psychological Association and the CINP. Dr. Rapaport received his bachelor’s degree from Revelle College at the University of California, San Diego (UCSD) and his medical degree from the UCSD School of Medicine.

Alan Schatzberg, M.D.
Professor and Chairman, Stanford University School of Medicine

Dr. Schatzberg is Professor and Chairman of the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. Dr. Schatzberg has been an active investigator in the biology and psychopharmacology of depressive disorders. He has explored norepinephrine systems in depression as a means of subtyping these disorders. His research has also given us major insights into the biological mechanisms that underlie the development of delusions in major depression and has opened innovative therapeutic strategies using glucocorticoid antagonists. Dr. Schatzberg has also been an active investigator in the clinical psychopharmacology of nondelusional depression with a particular recent interest in chronic depression and pharmacogenetics. He has co-authored over 550 publications and abstracts, including the Manual of Clinical Psychopharmacology, whose sixth edition was published in 2007. He also co-edited the Textbook of Psychopharmacology whose fourth edition appeared in 2007. He is Co-Editor-in-Chief of the Journal of Psychiatric Research and sits on many other editorial boards as well, including the Archives of General Psychiatry, Journal of Clinical Psychopharmacology, Psychoneuroendocrinology, Biological Psychiatry, and others. He is a Past President of the American College of Neuropsychopharmacology and the Society of Biological Psychiatry. He has received numerous Awards, including the 2002 Mood Disorders Research Award from the American College of Psychiatrists, the 2002 American Psychiatric Association Award for Research, the 2005 Distinguished Service in Psychiatry Award from the American College of Psychiatrists, the 2005 Falcone Award from NARSAD, etc. In 2003, he was elected into the Institute of Medicine of the National Academy of Sciences.